Publication digests
The Publication Digests section of this Learning Zone provides simplified detail and graphical summaries of the latest published research on atopic dermatitis.
The brief summaries of peer-reviewed articles in this section describe:
- First line treatments for atopic dermatitis and how more recent clinical data compare
- The mechanism of Janus kinase (JAK) inhibitors in targeting cytokines involved in atopic dermatitis
- Data from clinical trials of JAK inhibitors and other molecules being tested in treated atopic dermatitis
Discover results from a head-to-head, phase 3 atopic dermatitis clinical trial of systemic treatments in this publication digest.
Discover results from a head-to-head, phase 3 atopic dermatitis clinical trial of systemic treatments in this publication digest.
Skin pain improvements and improved quality of life in atopic dermatitis
Discover how baricitinib rapidly improves skin pain resulting in improved quality of life for patients with atopic dermatitis.
Results from replicate atopic dermatitis trials
Efficacy and safety profile of JAK inhibitor from two replicate atopic dermatitis trials
JAK inhibitor randomised AD trial results
Findings of the JADE MONO-2 trial that evaluated the safety profile and efficacy of JAK inhibitor monotherapy in atopic dermatitis
Comparison trial in atopic dermatitis
Safety profile and efficacy results of the (JADE) COMPARE trial in moderate-to-severe atopic dermatitis
of interest
are looking at
saved
next event
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.